1,248 results match your criteria: "Hospital of Montpellier[Affiliation]"
Crit Care Med
May 2024
Department of Anesthesia and Intensive Care Unit, Regional University Hospital of Montpellier, St-Eloi Hospital, University of Montpellier, PhyMedExp, INSERM, CNRS, Montpellier, France.
J Clin Med
March 2024
Cardiology Department, Montpellier University Hospital, Inserm U1046, CNRS UMR 9214, PhyMedExp, 34295 Montpellier, France.
: Acute heart failure (AHF) represents a leading cause of unscheduled hospital stays, frequent rehospitalisations, and mortality worldwide. The aim of our study was to develop a bedside prognostic tool, a multivariable predictive risk score, that is useful in daily practice, thus providing an early prognostic evaluation at admission and an accurate risk stratification after discharge in patients with AHF. : This study is a subanalysis of the STADE HF study, which is a single-centre, prospective, randomised controlled trial enrolling 123 patients admitted to hospital for AHF.
View Article and Find Full Text PDFJoint Bone Spine
September 2024
University of Paris-Cité, Department of Rheumatology, Hôpital Cochin, Assistance publique-Hôpitaux de Paris, Inserm (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris, France. Electronic address:
Introduction: National and international scientific societies advocate for a regular, systematic, and standardized global evaluation of axial spondyloarthritis (axSpA) patients. However, there are no recommendations specifying the content of this global evaluation. This initiative aimed to propose a standardized reporting framework, using evidence-based and consensus approaches, to collect data on all domains of axSpA.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
September 2024
Department of Clinical Genetics, Pellegrin University Hospital of Bordeaux, Bordeaux, France.
JHEP Rep
April 2024
Hepatology and liver transplantation department, Saint Eloi Hospital, 80 rue Augustin Fliche, 34295 Montpellier CEDEX 5, University Hospital of Montpellier, France.
Obes Res Clin Pract
May 2024
Nutrition-Diabetes Department, University Hospital of Montpellier, Montpellier, France; UMR 1302, Institute Desbrest of Epidemiology and Public Health, Univ Montpellier, INSERM, University Hospital of Montpellier, Montpellier, France.
We present for the first-time efficacy and tolerability of GLP-1-RA (Semaglutide) in Smith-Kingsmore syndrome (SKS). SKS is a rare genetic disorder characterized by intellectual disability, macrocephaly, seizures and distinctive facial features due to MTOR gene mutation. We present a 22-year-old woman with mosaic SKS and severe obesity (Body Mass Index ≥40 kg/m²), treated with semaglutide.
View Article and Find Full Text PDFHPB (Oxford)
June 2024
Department of Visceral and Digestive Surgery, University Hospital of Strasbourg, Strasbourg, France; Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques, U1110, Strasbourg, France; Institut Hospitalo-Universitaire (IHU), Institute of Image-Guided Surgery, Strasbourg, France. Electronic address:
Acta Derm Venereol
March 2024
Department of Dermatology, University Hospital of Montpellier, Montpellier, France; University of Montpellier, Montpellier, France.
The impact of chronic urticaria on work has been scarcely reported, whereas its peak incidence is between the ages of 20 and 40. The aim of this study was to assess the occupational impact of chronic urticaria and its treatment, by combining objective and patient-reported data. A monocentric observational study was performed using questionnaires over a 1-year period from 2021 to 2022 in chronic urticaria patients who were in a period of professional activity and agreed to participate.
View Article and Find Full Text PDFClin Exp Allergy
May 2024
Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
Background: The symptoms of house dust mite (HDM)-induced allergic rhinitis (AR) vary with changes in exposure related to the weather or the domestic environment. In allergen immunotherapy (AIT) studies, a certain level of AR disease activity is necessary to demonstrate treatment efficacy; the latter can be underestimated if a substantial proportion of the patient population is weakly symptomatic.
Objective: To better estimate the real treatment effect of a HDM sublingual AIT (SLIT) tablet, we analysed the results of natural field studies in detail by applying a tertile approach.
Arch Pediatr
April 2024
Department of Clinical Neurophysiology-Sleep Disorders Unit, University of Lille, University Hospital of Lille, and U1172 - LilNCog - Lille Neurosciences & Cognition, Lille 59000, France.
BMJ Open
March 2024
Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
Objectives: To explore the relationship between physical activity over a 10-year period and current symptoms of insomnia, daytime sleepiness and estimated sleep duration in adults aged 39-67.
Design: Population-based, multicentre cohort study.
Setting: 21 centres in nine European countries.
J Cyst Fibros
July 2024
IRCCS Istituto Giannina Gaslini, Cystic Fibrosis Center, Genoa, Italy.
This is the third paper in the series providing updated information and recommendations for people with cystic fibrosis transmembrane conductance regulator (CFTR)-related disorder (CFTR-RD). This paper covers the individual disorders, including the established conditions - congenital absence of the vas deferens (CAVD), diffuse bronchiectasis and chronic or acute recurrent pancreatitis - and also other conditions which might be considered a CFTR-RD, including allergic bronchopulmonary aspergillosis, chronic rhinosinusitis, primary sclerosing cholangitis and aquagenic wrinkling. The CFTR functional and genetic evidence in support of the condition being a CFTR-RD are discussed and guidance for reaching the diagnosis, including alternative conditions to consider and management recommendations, is provided.
View Article and Find Full Text PDFAm J Surg Pathol
May 2024
Department of Pathology, Institut of Pathologie Multisite, Groupement Hospitalier Sud, Hospices Civils de Lyon.
Pediatr Dermatol
March 2024
Department of Pediatric Infectious Diseases and Immunology, Arnaud de Villeneuve University Hospital of Montpellier, Montpellier, France.
Br J Anaesth
June 2024
Department of Anesthesia and Intensive Care, Strasbourg University Hospital, Strasbourg, France.
Am Heart J
June 2024
Department of Anesthesiology and Critical Care Medicine, Dijon University Medical Centre, 21000 Dijon, France; University of Burgundy and Franche-Comté, LNC UMR1231, F-21000 Dijon, France.
Background: Cardiac surgery-associated acute kidney injury (CS-AKI) affects up to 30% of patients, increasing morbidity and healthcare costs. This condition results from complex factors like ischemia-reperfusion injury and renal hemodynamic changes, often exacerbated by surgical procedures. Norepinephrine, commonly used in cardiac surgeries, may heighten the risk of CS-AKI.
View Article and Find Full Text PDFClin Exp Allergy
June 2024
Anaphylaxis Working Group of the French Allergy Society, Lille, France.
J Allergy Clin Immunol Pract
May 2024
Service de Pneumologie A, APHP Hôpital Bichat, Paris, France; Université de Paris Cité, Inserm 1152, Paris, France.
Ann Neurol
June 2024
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Objective: To apply a machine learning analysis to clinical and presynaptic dopaminergic imaging data of patients with rapid eye movement (REM) sleep behavior disorder (RBD) to predict the development of Parkinson disease (PD) and dementia with Lewy bodies (DLB).
Methods: In this multicenter study of the International RBD study group, 173 patients (mean age 70.5 ± 6.
Eur J Heart Fail
May 2024
Université de Paris, CRESS, INSERM, INRA, URCEco, AP-HP, Hôpital de l'Hôtel Dieu, Paris, France.
Aims: Evaluating the benefit of telemonitoring in heart failure (HF) management in real-world settings is crucial for optimizing the healthcare pathway. The aim of this study was to assess the association between a 6-month application of the telemonitoring solution Chronic Care Connect™ (CCC) and mortality, HF hospitalizations, and associated costs compared with standard of care (SOC) in patients with a diagnosis of HF.
Methods And Results: From February 2018 to March 2020, a retrospective cohort study was conducted using the largest healthcare insurance system claims database in France (Système National des Données de Santé) linked to the CCC telemonitoring database of adult patients with an ICD-10-coded diagnosis of HF.
Pediatr Allergy Immunol
February 2024
Pediatric Allergy Unit, Department of Pediatrics, Gynecology and Obstetrics, University Hospitals of Geneva, Geneva, Switzerland.
Ann Biol Clin (Paris)
February 2024
Department of Hormonology, Metabolism, Nutrition and Oncology, University Hospital of Lille, Lille, France.
The recreational use of nitrous oxide (N2O) is an emerging public health issue. Chronic N2O abuse may result in various clinical symptoms, encompassing neurological, psychiatric and cardiovascular outcomes. Despite the difficulties for the laboratory investigation of N2O intoxication, there is currently no guidelines in France to help both clinicians and biologists use appropriate biomarkers for the diagnosis and monitoring of patients with clinical symptoms potentially related to N2O intoxication.
View Article and Find Full Text PDFEur J Cancer
April 2024
Department of ENT-Head and Neck Surgery, Tenon University Hospital, APHP, Sorbonne Universite, 75020 Paris, France. Electronic address:
Objectives: To analyse prognostic factors and survival outcomes of malignant tumors of the external auditory canal, to investigate the role of regional surgery, and adjuvant radiotherapy in early stages and to investigate the role of surgery in operable T4 stage.
Setting: A retrospective analysis was conducted on all patients prospectively included in the national database of the French Expertize Network for Rare ENT Cancers (REFCOR) from January 2000 to December 2016.
Participants: 103 patients from 19 reference centers were included.
World Allergy Organ J
March 2024
Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
Int J Speech Lang Pathol
February 2024
Department of Speech-Language Pathology, University of Montpellier, Montpellier, France.
Purpose: The influential relationship between executive functioning and aphasia rehabilitation outcomes has been addressed in a number of studies, but few have studied the effect of adding executive function training to linguistic therapies. The present study aimed to measure the effects of combining, within therapy sessions, executive function training and anomia therapy on naming and discourse abilities in people with chronic aphasia.
Method: A single-case experimental design with multiple baselines across participants was used.